Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Früh

Showing results (501-510 of 552) with videos related to

Pageof 56
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2025
Glycoprotein L-deleted single-cycle rhesus cytomegalovirus vectors elicit MHC-E-restricted CD8+ T cells that protect against SIVScott G Hansen, John B Schell, Emily E Marshall, et al.
The European Respiratory Journal|August 12, 2017
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patientsMyriam Delaunay, Jacques Cadranel, Amélie Lusque, et al.
JCI Insight|February 7, 2023
Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIVScott G Hansen, Jennie L Womack, Wilma Perez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2019
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF TrialMiguel-Angel Molina-Vila, Rolf A Stahel, Urania Dafni, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2025
A nonhuman primate model mirrors human congenital cytomegalovirus infection and reveals a spectrum of vertical transmission outcomesTabitha Manuel, Matilda Moström, Chelsea M Crooks, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2025
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trialR A Soo, K Vervita, M Früh, et al.
Science (New York, N.Y.)|March 26, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacyMarieke C Verweij, Scott G Hansen, Ravi Iyer, et al.
Circulation|January 1, 2013
Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter studyJan Janoušek, Irene E van Geldorp, Sylvia Krupičková, et al.
Oncology|May 21, 2026
Decision making in intrathecal therapy for leptomeningeal diseaseSusanne Weindler, Thomas Hundsberger, Alfredo Addeo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO expertsPaul M Putora, Markus Glatzer, José Belderbos, et al.
Pageof 56

Showing results (501-510 of 552) with videos related to

Sort By:
Pageof 56
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2025
Glycoprotein L-deleted single-cycle rhesus cytomegalovirus vectors elicit MHC-E-restricted CD8+ T cells that protect against SIVScott G Hansen, John B Schell, Emily E Marshall, et al.
The European Respiratory Journal|August 12, 2017
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patientsMyriam Delaunay, Jacques Cadranel, Amélie Lusque, et al.
JCI Insight|February 7, 2023
Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIVScott G Hansen, Jennie L Womack, Wilma Perez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2019
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF TrialMiguel-Angel Molina-Vila, Rolf A Stahel, Urania Dafni, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2025
A nonhuman primate model mirrors human congenital cytomegalovirus infection and reveals a spectrum of vertical transmission outcomesTabitha Manuel, Matilda Moström, Chelsea M Crooks, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2025
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trialR A Soo, K Vervita, M Früh, et al.
Science (New York, N.Y.)|March 26, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacyMarieke C Verweij, Scott G Hansen, Ravi Iyer, et al.
Circulation|January 1, 2013
Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter studyJan Janoušek, Irene E van Geldorp, Sylvia Krupičková, et al.
Oncology|May 21, 2026
Decision making in intrathecal therapy for leptomeningeal diseaseSusanne Weindler, Thomas Hundsberger, Alfredo Addeo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO expertsPaul M Putora, Markus Glatzer, José Belderbos, et al.
Pageof 56